Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: The Swedish experience

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 10, 2014, Pages 1116-1121

  Burman, Joachim ^a,b   Iacobaeus, Ellen ^c   Svenningsson, Anders ^d   Lycke, Jan ^e   Gunnarsson, Martin ^f,g   Nilsson, Petra ^h   Vrethem, Magnus ^i,j   Fredrikson, Sten ^c   Martin, Claes ^k   Sandstedt, Anna ^l   Uggla, Bertil ^f,g   Lenhoff, Stig ^h   Johansson, Jan Erik ^e   Isaksson, Cecilia ^m   Hägglund, Hans ^b   Carlson, Kristina ^b   Fagius, Jan ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^g ÖREBRO UNIVERSITY   (Sweden)

^h LUND UNIVERSITY HOSPITAL   (Sweden)

ⁱ LINKÖPING UNIVERSITY   (Sweden)

^j Centre of Surgery and Oncology   (Sweden)

^k DANDERYD HOSPITAL   (Sweden)

^l LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^m UMEÅ UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALOPECIA; ANEMIA; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTEREMIA; CHILD; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; CROHN DISEASE; DEEP VEIN THROMBOSIS; DISEASE FREE SURVIVAL; EPILEPSY; EVENT FREE SURVIVAL; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HERPES ZOSTER; HUMAN; LEUKOPENIA; MALE; MULTIPLE SCLEROSIS; NOROVIRUS INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PATIENT SAFETY; PREGNANCY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PYELONEPHRITIS; RECURRENCE FREE SURVIVAL; SWEDISH CITIZEN; SYSTEMIC MYCOSIS; THROMBOCYTOPENIA; THYROID DISEASE; TREATMENT OUTCOME; TYPHLITIS; VIRUS REACTIVATION; AUTOTRANSPLANTATION; BRAIN; DISABILITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MIDDLE AGED; MORTALITY; NEUROIMAGING; PATHOLOGY; RECURRENT DISEASE; SWEDEN; YOUNG ADULT;

MULTIPLE SCLEROSIS;

ADOLESCENT; ADULT; BRAIN; CHILD; DISABILITY EVALUATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROIMAGING; RECURRENCE; SWEDEN; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84908335130     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2013-307207     Document Type: Article

References (18)

1. Fassas A, Anagnostopoulos A, Kazis A, et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant 1997; 20:631-8.
2. Burt RK, Cohen BA, Russell E, et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood 2003; 102:2373-8.
3. Fagius J, Lundgren J, Öberg G. Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation. Mult Scler 2008; 15:229-37.
4. Burt R, Loh Y, Cohen B, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol 2009; 8:244-53.
5. Krasulova E, Trneny M, Kozak T, et al. High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience. Mult Scler 2010; 16:685-93.
6. Mancardi G, Sormani M, Di Gioia M, et al. Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience. Mult Scler J 2012; 18:835-42.
7. Fassas A, Kimiskidis VK, Sakellari I, et al. Long-term results of stem cell transplantation for MS: a single-center experience. Neurology 2011; 76:1066-70.
8. Hintzen RQ Stem cell transplantation in multiple sclerosis: multiple choices and multiple challenges. Mult Scler 2002; 8:155-60.
9. Muraro P, Douek D, Packer A, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med 2005; 201:805-16.
10. Darlington PJ, Touil T, Doucet JS, et al. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Ann Neurol 2013; 73:341-54.
11. Burman J, Fransson M, Totterman TH, et al. T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis. Immunology 2013; 140:211-19.
12. Saccardi R, Kozak T, Bocelli-Tyndall C, et al. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler 2006; 12:814-23.
13. Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-52.
14. Shevchenko JL, Kuznetsov AN, Ionova TI, et al. Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis. Exp Hematol 2012; 40:892-8.
15. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/ MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995; 45:1277-85.
16. Fassas A, Nash R. Stem cell transplantation for autoimmune disorders. Multiple sclerosis. Best Pract Res Clin Haematol 2004; 17:247-62.
17. Hankey GJ, Spiesser J, Hakimi Z, et al. Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurology 2007; 68:1583-7.
18. Coles AJ Alemtuzumab therapy for multiple sclerosis. Neurotherapeutics 2013; 10:29-33.